| Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210) |
|---|
| 03/03/2005 | US20050048615 Adipocyte complement related protein zacrp11 |
| 03/03/2005 | US20050048609 Fluorescent protein for use as diagnostic indicator in transformed plant or fish cells; biosensors |
| 03/03/2005 | US20050048608 Mammalian host cells for enhanced expression of a recombinant protein; bioreactors and genetic engineering |
| 03/03/2005 | US20050048606 Recombinant polypeptide useful for neurotrophin receptor mediated gene delivery and as neurotrophin agonist |
| 03/03/2005 | US20050048605 Novel polypeptide dna thereof and use of the same |
| 03/03/2005 | US20050048604 Site directed mutatgenesis; deletions; transferases; hybridization probes |
| 03/03/2005 | US20050048603 Expression of membrane proteins using an adenylyl cyclase of mycobacterium tube rculosis |
| 03/03/2005 | US20050048590 Streptococcal enolase for use in generating immunoglobulins for use in prevention and treatment of microorganismal infection; immunotherapy |
| 03/03/2005 | US20050048586 Using taste transduction G-protein coupled receptor polypeptides as diagnostic tools which identify modulators which enhance flavors and taste |
| 03/03/2005 | US20050048584 Method for detecting alzheimer's disease and differentiating alzheimer's disease from other demential diseases associated peptides and use thereof |
| 03/03/2005 | US20050048581 Imaging morphologies and subcellular architectures of ultrasmall structures within cells |
| 03/03/2005 | US20050048580 Microarray for use in producing a protein-interaction map; proteomics, genomics and high throughput analysis |
| 03/03/2005 | US20050048578 Methods of screening for monoclonal antibodies with desirable activity |
| 03/03/2005 | US20050048577 Methods of using cytokine receptor zalpha11 to detect its ligands |
| 03/03/2005 | US20050048570 Solid support comprising microstructures containing biofunctionalized nanoparticles for use in detecting infection; disease diagnosis; bioinformatics |
| 03/03/2005 | US20050048559 Compositions and methods relating to breast specific genes and proteins |
| 03/03/2005 | US20050048557 Expression vector comprising nucleotide sequences coding microorganismsal protein for use in developing vaccine agents which prevent bacterial infection; bactericides; microbiocides |
| 03/03/2005 | US20050048556 Expression vector comprising nucleotide sequences coding polypeptides which confer herbicide resistance to plants; tissue engineering and biological pest comtrol |
| 03/03/2005 | US20050048552 Higher order structure and binding of peptide nucleic acids |
| 03/03/2005 | US20050048549 Expression vector comprising regulatory nucleotide sequences for use in identifying modulator of gene expression; identifying modulators which control gene expression via acting untranslated regions of messe ger RNA |
| 03/03/2005 | US20050048548 Surface display of selenocysteine-containing peptides |
| 03/03/2005 | US20050048540 Multicompartment apparatus comprising gene binding carrier and injection ports for use in isolation, characterization and extraction of preferential gene sequences |
| 03/03/2005 | US20050048537 Novel human lipocalin homologs and polynucleotides encoding the same |
| 03/03/2005 | US20050048536 Gilvocarcin gene cluster, recombinant production and use thereof |
| 03/03/2005 | US20050048530 Replicating nucleotide sequences in high hydrogen ion conentration environment via mixture comprising modified thermostable polymerase and amplification enhancing factors |
| 03/03/2005 | US20050048529 RNA interference mediated inhibition of intercellular adhesion molecule (ICAM) gene expression using short interfering nucleic acid (siNA) |
| 03/03/2005 | US20050048528 Using immunoglobulins and diagnostic and/or prognostic tool for detection and treatment of cell proliferative disorders; immunodiagnostics; immunotherapy |
| 03/03/2005 | US20050048525 Amino acid sequences having hydrolase enzyme activity for use diagnosis, prevention and treatment of cardiovascular and gastrointestinal disorders; drug screening; bioassay |
| 03/03/2005 | US20050048524 Using intergenic transcribed spacer (ITS) as tool in characterizing and classifiying enterobacterium |
| 03/03/2005 | US20050048523 Nucleic acid molecules encoding multiple start codons and histidine tags |
| 03/03/2005 | US20050048522 Novel guanosine triphosphate (GTP) binding protein-coupled receptor proteins |
| 03/03/2005 | US20050048520 Nogo receptor homologs |
| 03/03/2005 | US20050048511 Truncated glycogen synthase kinase 3 protein for use in identifying modulators to treat diabetes, inflammation and nervous system disorders; drug screening |
| 03/03/2005 | US20050048508 Trehalose receptor and method for detecting trehalose with the same |
| 03/03/2005 | US20050048488 Expression vector comprising nucleotide sequences coding excitatory amino acid transporter 2 (EAAT2) proteins for use in identifying modulator for treatment and preention of neurological or psychiatric disorder |
| 03/03/2005 | US20050048487 Such as thrombin binding aptamer attached by terminal phosphate to amino sepharose via carbodiimide mediated coupling |
| 03/03/2005 | US20050048486 Method of inactivating ribonucleases at high temperature |
| 03/03/2005 | US20050048484 Cytochrome p450 monooxygenases consisting of thermophilic bacteria |
| 03/03/2005 | US20050048483 Novel secreted proteins and their uses |
| 03/03/2005 | US20050048481 Markers for detecting plant genome polymorphism with the use of transposable element and method of constructing the same |
| 03/03/2005 | US20050048480 Method of detecting cancer |
| 03/03/2005 | US20050048479 Adenylyl and guanylyl cyclases |
| 03/03/2005 | US20050048478 Preparing agents which prevent and/or treat viral diseases; immunotherapy; mimetics |
| 03/03/2005 | US20050048476 Expression vector comprising tumor necrosis factor fusion for use in identifying modulator for treatment of cell proliferaive disorders; antitumor agents |
| 03/03/2005 | US20050048471 Albumin derivatives with therapeutic functions |
| 03/03/2005 | US20050048470 Expression vector comprising nucleotide sequences coding recombinase inhibitor for use in treatment and prevention of viral infcetion and diseases |
| 03/03/2005 | US20050048467 Method and compositions relating to hpv-associated pre-cancerous and cancerous growths, including cin |
| 03/03/2005 | US20050048466 Recombinant virus comprising virus proliferating essential gene (VPEG) for use in the treatment of cell proliferative disorders; cancer therapeutics |
| 03/03/2005 | US20050048108 Using cephalins as complexing agent for gene therapy, diagnosis |
| 03/03/2005 | US20050048076 Mutant endotoxin for use in prevention of bacterial infections; bactericides; microbiocides |
| 03/03/2005 | US20050048075 Protein isolation |
| 03/03/2005 | US20050048074 Transgenic plant comprising nucleotide sequences coding hemagglutinin-neuraminidase (HN) proteins of newcastle disease viruses; for use in producing immunoprotective particles; vaccine preparation |
| 03/03/2005 | US20050048073 Methods of determining west nile virus epitopes and method of using the same |
| 03/03/2005 | US20050048070 Mixture of polypeptides from cytokeratins; anticancer agnets; vaccines |
| 03/03/2005 | US20050048068 Major histocompatibility complex epitopes; immunotherapy ; induce immunology response |
| 03/03/2005 | US20050048064 Chemical modification of single chain polypeptides by means of covalent attachment of strands of polyethylene glycol to single chain polypeptide binding molecules that have three dimensional folding and binding ability |
| 03/03/2005 | US20050048055 Use of CD40 engagement to alter T cell receptor usage |
| 03/03/2005 | US20050048053 Humanization of an anti-carcinoembryonic antigen anti-idiotype antibody as a tumor vaccine and for targeting applications |
| 03/03/2005 | US20050048052 Bioassay for detecting expression of mammalian CC-chemokine receptor 2, by binding of antibody or antigen-binding fragment; human or humanized monoclonal antibody; test kits |
| 03/03/2005 | US20050048051 Using mixtuire of antibodies ; aggregated by immobilized streptavidin; culture product |
| 03/03/2005 | US20050048049 A humanized antibody that binds to soluble A beta; may be monoclonal, polyclonal, single chain or fused to a heterologous polypeptide |
| 03/03/2005 | US20050048043 Methods for in vivo gene transfer into pancreatic and biliary epithelial cells |
| 03/03/2005 | US20050048041 Gene product used for neurodegenerative disorders; homologous recombination; insertion of gene into nucleic acids |
| 03/03/2005 | US20050048039 Administering exogenous monocyte cells loaded with corrective agent; chemotactic factor for macrophages; diagnosis of bone disorders, anticarcinogenic agents, rheumatic disorders; Alzheimer's disease; Parkinson's disease; Huntington's disease; multiple sclerosis; stroke |
| 03/03/2005 | US20050048038 Efficient production of f(ab')2 fragments in mammalian cells |
| 03/03/2005 | US20050048031 Defective recombinant adenoviruses expressing cytokines for antitumor treatment |
| 03/03/2005 | US20050048030 Parainfluenza virus, respiratory syncytial virus infection genetic engineering vectors; heterologous nucleic acids |
| 03/03/2005 | US20050048029 Nucleotide sequence for diagnosis, prevention, therapy of cancer, inflammation, autoimmune disease and infections |
| 03/03/2005 | US20050048028 Use of the insulin-like-growth factor i splice variant mgf for the prevention of myocardial damage |
| 03/03/2005 | US20050047998 Phosphoprotein target for insulin and its antagonists |
| 03/03/2005 | US20050047996 Calibration of colorectal cancer; gene expression profile; administering to human an antibody which binds to protein markers |
| 03/03/2005 | US20050047973 Fully automated and parameter regulated; simultaneous performance of polymerase chain reaction and microarray based testing in single chamber system; simple construction, low manufacturing cost; reproducibility; preventing contamination |
| 03/03/2005 | US20050047640 Method and device for selectively targeting cells within a three-dimensional specimen |
| 03/03/2005 | US20050046833 Gigamatrix holding tray having through-hole wells |
| 03/03/2005 | DE10337368A1 Diagnosis of pancreatic cancer by detecting expression of the a disintegrin and metalloprotease domain 9 (ADAM9) protein using specific antibodies, also therapeutic use of these antibodies and of ADAM9-specific nucleic acids |
| 03/03/2005 | DE10334811A1 Use of gene-expression system comprising desaturase promoter for temperature regulated-expression of heterologous genes and producing thermolabile proteins that are difficult to fold or are cold adapted |
| 03/03/2005 | CA2816222A1 Influenza hemagglutinin and neuraminidase variants |
| 03/03/2005 | CA2541241A1 A continuous process for the assembly of macromolecular substances and the subsequent capture and isolation of a macromolecular assembly, and a system suitable for the process |
| 03/03/2005 | CA2537263A1 Techniques and compositions for the diagnosis and treatment of cancer (muc1) |
| 03/03/2005 | CA2536946A1 Estrogen receptor modulators and uses thereof |
| 03/03/2005 | CA2536495A1 Promoter of synoviolin gene |
| 03/03/2005 | CA2536492A1 Process for producing cytotoxic lymphocytes |
| 03/03/2005 | CA2536408A1 Improved antibodies having altered effector function and methods for making the same |
| 03/03/2005 | CA2536328A1 Method of examining colon cancer and colon adenoma |
| 03/03/2005 | CA2536320A1 Nucleotide sequences and polypeptides encoded thereby useful for increasing plant size and increasing the number and size of leaves |
| 03/03/2005 | CA2536317A1 Poxvirus vector encoding prostate specific antigens for treatment of prostate cancer |
| 03/03/2005 | CA2536112A1 Methods for enhancing embryo viability |
| 03/03/2005 | CA2536086A1 Inhibition of dr3 in the treatment of allergic lung inflammation |
| 03/03/2005 | CA2536071A1 Methods for detecting regulatory effect on synoviolin activity |
| 03/03/2005 | CA2535976A1 A novel gene and protein associated with angiogenesis and endothelial apoptosis |
| 03/03/2005 | CA2535972A1 Method for producing ketocarotinoids in genetically modified, non-human organisms |
| 03/03/2005 | CA2535921A1 Novel rat calcium channel subunits and related probes, cell lines and methods |
| 03/03/2005 | CA2535859A1 Endotheliase-2 ligands |
| 03/03/2005 | CA2535807A1 Peptides with the capacity to bind to transforming growth factor .beta.1 (tgf-.beta.1) |
| 03/03/2005 | CA2535799A1 Identification of porphyromonas gingivalis virulence polynucleotides for diagnosis, treatment, and monitoring of periodontal diseases |
| 03/03/2005 | CA2535763A1 Reduced-exposure tobacco products |
| 03/03/2005 | CA2535754A1 Human autism susceptibility gene and uses thereof |
| 03/03/2005 | CA2535753A1 Neurogenin3 and production of pancreatic islet cells |
| 03/03/2005 | CA2535745A1 Anti-bacterial composition, especially for controlling gram-negative bacteria, comprising a peptide and an advantageously hydrophobic anti-bacterial agent |
| 03/03/2005 | CA2535585A1 Pharmaceutical composition for preventing or remedying cardiac hypertrophy and cardiocascular disease caused thereby |